4 Stocks Fueling Telehealth's Explosive Growth

The U.S. telehealth market is expected to grow 56% over the next four years. How can Cigna, WellPoint, UnitedHealth, and Google benefit from this trend?

Jun 21, 2014 at 1:45PM

The U.S. telehealth market will grow from $240 million in 2013 to $1.9 billion by 2018, according to research firm IHS, at an annual growth rate of 56%. RNCOS Business Consultancy Services expects the worldwide telehealth market to grow 18.5% annually.

Those impressive growth rates indicate that the soaring adoption of mobile devices will allow more doctors to treat a higher number of patients via the Internet. Onboard cameras, motion sensors, fitness tracking apps, and attached peripherals on smartphones and tablets can now help doctors remotely monitor a wider array of health conditions than ever before.

Therefore, it makes sense for insurers and tech companies to develop software which streamlines telehealth services for doctors and patients. Let's take a closer look at four notable efforts from Cigna (NYSE:CI), WellPoint (NYSE:ANTM), UnitedHealth Group (NYSE:UNH), and Google (NASDAQ:GOOG) (NASDAQ:GOOGL).

Cigna and MD Live
Last April, Cigna signed a deal with MDLive, a telehealth service which provides patient-to-doctor remote visits via iOS devices and PCs. MDLive's remote consultations can be conducted via email, video chat, or phone conversations. The results are then recorded with the patient's primary care provider.


MDLive's iPhone app. Source: iTunes

Cigna's members will have access to MDLive's 2,200 on-call physicians across the country. Cigna members can either schedule an appointment or request an immediate consultation, which requires an average wait of 11 minutes. A waiting patient is then notified both via a text message and email when the doctor is available. These services only cover nonemergency issues such as colds, the flu, rashes, sinus issues, and headaches.

In an interview at Mobihealth, MDLive CEO Randy Parker stated that 70% of ER visits could have been avoided with the help of a remote consultation like MDLive. Since ER visits can be costly for both the patient and the insurer (often topping $1,500), it makes sound business sense for Cigna to offer its members a service that can resolve potential problems at home.

WellPoint and UnitedHealth
WellPoint has partnered with American Well, which provides a telehealth service called LiveHealth Online to members in 44 states and Washington, D.C.

American Well's 10-minute sessions are conducted over video chat with on-call, board-certified doctors. Physicians can prescribe medications if the state allows prescriptions via online video sessions. WellPoint launched its version of American Well's software in California and Ohio last year, and plans to deploy the service to more states over the next few years.

UnitedHealth Group's OptumHealth has also launched a similar telehealth effort, NowClinic, which is now available in two dozen states. Like Cigna and WellPoint's partnerships, NowClinic is conducted over video chat, only used for nonemergency situations, and physicians in certain states can prescribe medications. Rite Aid, the third largest pharmacy in America, now offers NowClinic services (online diagnosis and prescriptions) at select locations.


NowHealth's iPhone app. Source: iTunes

Google Helpouts
Last November, Google launched Helpouts, a marketplace for certified experts to charge clients for consultations in various fields. These consultations can be charged per session, per minute, or both, and are paid via a client's Google Wallet. Members must access the service via a Google+ account.

Google usually takes a 20% cut of the fee, but it has waived that fee for health-related questions. One Medical, a network of medical practices that emphasizes the use of telehealth, provides Google Helpouts members remote access to dozens of clinics and hundreds of doctors within its network. One Medical's sessions, which also focus on nonemergency conditions, generally last for 20 minutes.

One Medical's network accepts health plans from most major insurers -- including Cigna, WellPoint, and UnitedHealth -- which means that Helpouts could be another way for insurers to expand into regions which their telehealth partners have not reached yet.

The road ahead
In closing, telehealth is appealing to insurers because it can keep patients healthy while reducing the number of costly hospital visits. It also prevents members from erroneously self-diagnosing themselves and scrambling to the ER in a panic. In the near future, biometric data collected from fitness trackers, medical devices, and mobile apps will likely play key roles in telehealth as well.

But before that happens, telehealth providers and insurers must secure their patient-doctor exchanges to remain compliant with HIPAA regulations. Medicare coverage of telehealth should be expanded to include more features, including the exchange of digital images. Moreover, all states still have to legalize telehealth and allow the prescriptions of basic medications via video chat. Only then can the U.S. telehealth market achieve the double-digit growth that IHS expects.

Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.


Leo Sun owns shares of Google (C shares). The Motley Fool recommends Google (A shares), Google (C shares), UnitedHealth Group, and WellPoint. The Motley Fool owns shares of Google (A shares), Google (C shares), and WellPoint. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information